Abstract
The role of hepatic resection for hepatocellular carcinoma (HCC) in different Barcelona Clinic Liver Cancer (BCLC) stages is controversial. We aimed at measuring the survival benefit of resection vs. non-surgical-therapies in each BCLC stage.
Lingua originale | English |
---|---|
pagine (da-a) | 617-624 |
Numero di pagine | 8 |
Rivista | Journal of Hepatology |
Volume | 62 |
DOI | |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- Best supportive care
- Cirrhosis
- Hepatocellular carcinoma
- Liver resection
- Loco-regional therapies
- Survival benefit